SEARCH

SEARCH BY CITATION

References

  • 1
    Hennies HH, Friderichs E, Schneider J. Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneim-Forsch/Drug Res 1988; 38: 87780.
  • 2
    Collart L, Luthy C, Dayer P. Partial inhibition of tramadol antinociceptive effect by naloxone in man. Br J Clin Pharmacol 1993: 35: 73P.
  • 3
    Besson J-M, Chaouch A. Peripheral and spinal mechanisms of nociception. Physiol Rev 1987; 67: 67186.
  • 4
    Kayser V, Besson J-M, Guilbaud G. Evidence for a noradrenergic component in the antinociceptive effect of the analgesic agent tramadol in an animal model of clinical pain, the arthritic rat. Eur J Pharmacol 1992; 224: 8388.
  • 5
    Hennies HH, Friderichs E, Wilsmann K, Flohé L. Effect of the opioid analgesic tramadol on inactivation of norepinephrine and serotonin. Biochem Pharmacol 1982; 31: 16541655.
  • 6
    Raffa RB, Friderichs E, Reinman W, Shank RP, Codd EE, Vaught JL. Opioid and non opioid component contribute to the mechanism of action of tramadol an atypical opioid analgesic. J Pharmacol Exp Ther 1992; 260: 275285.
  • 7
    Raffa RB, Friderichs E, Wolfgang R, et al. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther 1993; 287: 331339.
  • 8
    Goldberg MR, Robertson D. Yohimbine a pharmacological probe for the study of the alpha adrenoreceptor. Pharmacol Rev 1983; 35: 143180.
  • 9
    Herner BE, Edvinson L, Hedner J, Persson B, Petterson A. Yohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteers. Eur J Clin Pharmacol 1992: 43: 651656.
  • 10
    CPMP working party on efficacy of medicinal products note for guidance. Good Clinical Practice Trials on Medicinal Products in the European Community. Commission of the European Communities 111/3976/88-EN Final, 1991. Idanpaan-Heikkila JE. WHO guidelines for good clinical practice for trials on pharmaceutical products: responsibilities of investigator. Ann Med 1994; 26: 8994.
  • 11
    Dayer P, Leemann T, Striberni R. Dextromethorphan O-demethylation in liver microsomes as a prototype reaction to monitor cytochrome P-450DB1 activity. Clin Pharmacol Ther 1989; 45: 3440.
  • 12
    Willer J-C. Comparative study of perceived pain and nociceptive flexion reflex in man. Pain 1977; 3: 6980.
  • 13
    Desmeules J, Dayer P, Gascon M-P, Magistris M. Impact of genetic and environmental factors on codeine analgesia. Clin Pharmacol Ther 1989; 45: 122.
  • 14
    Willer J-C. Exploration clinique de la nociception par des techniques de réflexologie. Neurophysiol Clin 1990; 20: 33556.
  • 15
    Porchet HC, Piletta P, Dayer P. Objective assessment of clonidine analgesia in man and influence of naloxone. Life Sci 1990; 46: 991998.
  • 16
    Piletta P, Porchet HC, Dayer P. Central analgesic effect of acetaminophen but not aspirin. Clin Pharmacol Ther 1991; 49: 350354.
  • 17
    Coquoz D, Porchet HC, Dayer P. Central analgesic effects of desipramine fluvoxamine, and moclobemide after single oral dosing: a study in healthy volunteers. Clin Pharmacol Ther 1993; 54: 340344.
  • 18
    Paalzow L. Analgesia produced by clonidine in mice and rats. J Pharm Pharmacol 1974; 26: 361363.
  • 19
    Paalzow G, Paalzow L. Clonidine anti-nociceptive activity, effects of drugs influencing central monoaminergic and cholinergic mechanism in the rat. Naunyn-Schmied Arch Pharmacol 1976: 292: 119126.
  • 20
    Yaksh TL. Pharmacology of spinal adrenergic system which modulates spinal nociceptive processing. Pharmacol Biochem Behav 1985; 22: 845858.
  • 21
    Wang YC, Su, CF, Lin MT. The site and the mode of analgesic actions exerted by clonidine in monkeys. Exp Neurol 1985; 90: 479488.
  • 22
    Solomon RE, Brody MJ, Gebhardt GF. Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine. J Pharmacol Exp Ther 1989; 251: 2738.
  • 23
    Proudfit HK. Behavioural pharmacology of noradrenergic descending system. In Towards the use of noradrenergic, agonists for the treatment of pain, eds Besson JM, Guilbaud G. Elsevier, Amsterdam, 1992: 119137.
  • 24
    Headley PM. Noradrenergic receptors in the dorsal horn of the spinal cord. In Towards the use of noradrenergic agonists for the treatment of pain, eds Besson JM, Guilbaud G. Elsevier, Amsterdam, 1992: 169181.
  • 25
    Fleetwood-Walker SM, Mitchell R, Hope PJ, Molony V, Iggo A. An alpha 2 receptor mediates the selective inhibition by noradrenaline of nociceptive responses of identified dorsal horn neurones. Brain Res 1985; 334: 243254.
  • 26
    Drasner K, Field HL. Synergy between the antinociceptive effects of intrathecal clonidine and systemic morphine in the rat. Pain 1988; 309312.
  • 27
    Kalso E, Sullivan AF, Rosenberg PH. Spinal antinociception by dexmethomidine, a highly selective alpha 2 adrenergic agonist. Pharmacol Toxicol 1991; 88: 140143.
  • 28
    Kayser V, Besson JM, Guilbaud G. Effects of the analgesic agent tramadol in normal and arthritic rats: comparison with the effects of different opioids, including tolerance and cross–tolerance to morphine. Eur J Pharmacol 1991; 195: 3745.
  • 29
    Kalso E, Sullivan AF, McQuay HJ, Dickenson AH, Roques BP. Cross-tolerance between mu opioid and alpha-2 adrenergic receptors. But not between mu and delta opioid receptors in the spinal cord of the rat. J Pharmacol Exp Ther 1993; 265: 551556.
  • 30
    Dayer P, Desmeules J, Leemann T, Striberni R. Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalysing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufl). Biochem Biophys Res Comm 1988; 152: 411416.
  • 31
    Dennis SG, Melzack R, Gutman S, Boucher F. Pain modulation by adrenergic agents and morphine as measured by three pain tests Life Sci 1980; 26: 12471259.
  • 32
    Iglesias V, Alguasil LF, Alamao C, Cuenca E. Effect of yohimbine on morphine analgesia and physical dependence in the rat. Eur J Pharmacol 1992; 21: 3538.
  • 33
    Elliott P, Wallis DI. Serotonin and L-norepinephrine as mediator of altered excitability in neonatal rat motoneurons studied in vitro. Neurosci 1992; 47: 533544.